3The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China.第二次中国临床血脂控制达标率及影响因素多中心协作研究[J].中华心血管病杂志,2007,35(5):420-427. 被引量:126
6Doll R, Peto R, Wheatley K, et aL Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ, 1994,309:901-911.
7National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III ) final report. Circulation, 2002, 106:3143-3421.
8Haffner SM, Lehto S, Ronnemaa T, et aL Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infaretion. N Engl J Med, 1998, 339:229-234.
9Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China : the China Heart Survey. Eur Heart J, 2006, 27: 2573-2579.
10Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk racers associated with myocardial infarction in 52 countries (the INTERHEART study) :case-control study. Lancet, 2004,364.937-952.